238O Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinomaM. Xie,C. He,J. HuangAnnals of Oncology(2015)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要